How can we help you?
Opportunities and challenges in generating and communicating evidence for COVID-19 treatments and vaccines.
We've grown from 26 employees at RTP in 2000 to over 350 worldwide in 2020.
We'll help you navigate and understand the emerging ISPOR/ISPE Real World Evidence guidelines.
Learn how a Market Access Evidence Roadmap can help you identify areas of evidence generation required to support reimbursement and increase access to your product.
The consortium working on EMA-funded MINERVA Project to aid RWD use, is being led by RTI-HS